These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11718183)

  • 1. Extrapyramidal effects of SSRI antidepressants.
    Prescrire Int; 2001 Aug; 10(54):118-9. PubMed ID: 11718183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors.
    Caley CF
    Ann Pharmacother; 1997 Dec; 31(12):1481-9. PubMed ID: 9416386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal Reactions Associated with Serotonergic Antidepressants.
    Hawthorne JM; Caley CF
    Ann Pharmacother; 2015 Oct; 49(10):1136-52. PubMed ID: 26185277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement disorders associated with the serotonin selective reuptake inhibitors.
    Leo RJ
    J Clin Psychiatry; 1996 Oct; 57(10):449-54. PubMed ID: 8909330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.
    Draper B; Berman K
    Drugs Aging; 2008; 25(6):501-19. PubMed ID: 18540689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.
    Lane RM
    J Psychopharmacol; 1998; 12(2):192-214. PubMed ID: 9694033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.
    Mazzucchi S; Frosini D; Ripoli A; Nicoletti V; Linsalata G; Bonuccelli U; Ceravolo R
    Acta Neurol Scand; 2015 Mar; 131(3):191-5. PubMed ID: 25274076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.
    Gill HS; DeVane CL; Risch SC
    J Clin Psychopharmacol; 1997 Oct; 17(5):377-89. PubMed ID: 9315989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
    Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.
    Prescrire Int; 2004 Apr; 13(70):57. PubMed ID: 15148974
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerability of paroxetine in Parkinson's disease: a prospective study.
    Tesei S; Antonini A; Canesi M; Zecchinelli A; Mariani CB; Pezzoli G
    Mov Disord; 2000 Sep; 15(5):986-9. PubMed ID: 11009210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
    Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
    Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.
    Ramasubbu R
    J Clin Psychiatry; 2004 Dec; 65(12):1642-53. PubMed ID: 15641869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
    Panisset M; Chen JJ; Rhyee SH; Conner J; Mathena J;
    Pharmacotherapy; 2014 Dec; 34(12):1250-8. PubMed ID: 25314256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin-reuptake inhibitor-induced movement disorders.
    Gerber PE; Lynd LD
    Ann Pharmacother; 1998 Jun; 32(6):692-8. PubMed ID: 9640489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.